肌管氨酸相关蛋白-7通过直接相互作用抑制突变 (G12V) K-RAS
Philip Weidner1, Daniel Saar2, Michaela Söhn1
1Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Cancer letters
|March 10, 2024
概括
Myotubularin相关蛋白-7 (MTMR7) 抑制了RAS信号传递,防止了癌症治疗的耐药性. MTMR7模仿对向胃肠道癌症的突变K-RAS显示出希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 癌症治疗耐药性通常涉及PI3K和Wnt信号通路的重新激活,在抑制K-RAS因子后.
- 已知Myotubularin-related-protein-7 (MTMR7) 抑制PI3K和ERK1/2信号传递,这些信号传递在RAS.
研究的目的:
- 调查MTMR7是否直接准RAS以防止癌症治疗抵抗.
- 探索MTMR7或其模仿剂对突变K-RAS癌症的治疗潜力.
主要方法:
- 使用了细胞和结构生物学技术.
- 在体外研究中,MTMR7在癌细胞中过度表达.
- 在体内研究中使用了与MTMR7-CC模仿的胃和肠癌小鼠模型.
主要成果:
- 表明MTMR7在细胞膜上结合并抑制RAS.
- 过度表达MTMR7降低了RAS活性,ERK1/2酸化和癌细胞增殖.
- 一种细胞透的MTMR7-CC仿真在小鼠癌症模型中降低了瘤生长和扩散标志物.
- MTMR7直接与K-RASG12V突变物相互作用,稳定其GDP-bound状态.
结论:
- MTMR7通过与细胞膜结合,直接抑制RAS信号传递.
- MTMR7模仿代表了一种针对癌症突变K-RAS的新型治疗策略,有可能克服治疗耐药性.
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Destabilization of Microtubules
2.7K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


